These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37995179)

  • 1. Alveolar type I cells can give rise to KRAS-induced lung adenocarcinoma.
    Yang M; Shen H; Flodby P; Koss MD; Bassiouni R; Liu Y; Jashashvili T; Neely A; Ogbolu E; Castillo J; Stueve TR; Mullen DJ; Ryan AL; Carpten J; Castaldi A; Wallace WD; Zhou B; Borok Z; Marconett CN
    Cell Rep; 2023 Dec; 42(12):113286. PubMed ID: 37995179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung Adenocarcinoma.
    Li Z; Zhuang X; Pan CH; Yan Y; Thummalapalli R; Hallin J; Torborg S; Singhal A; Chang JC; Manchado E; Dow LE; Yaeger R; Christensen JG; Lowe SW; Rudin CM; Joost S; Tammela T
    Cancer Discov; 2024 Feb; 14(2):308-325. PubMed ID: 37931288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell of origin alters myeloid-mediated immunosuppression in lung adenocarcinoma.
    Yang M; Shulkin N; Gonzalez E; Castillo J; Yan C; Zhang K; Arvanitis L; Borok Z; Wallace WD; Raz D; Torres ETR; Marconett CN
    bioRxiv; 2024 Jun; ():. PubMed ID: 38948812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-stage lung cancer is driven by a transitional cell state dependent on a KRAS-ITGA3-SRC axis.
    Moye AL; Dost AF; Ietswaart R; Sengupta S; Ya V; Aluya C; Fahey CG; Louie SM; Paschini M; Kim CF
    EMBO J; 2024 Jul; 43(14):2843-2861. PubMed ID: 38755258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS(G12D) drives lepidic adenocarcinoma through stem-cell reprogramming.
    Juul NH; Yoon JK; Martinez MC; Rishi N; Kazadaeva YI; Morri M; Neff NF; Trope WL; Shrager JB; Sinha R; Desai TJ
    Nature; 2023 Jul; 619(7971):860-867. PubMed ID: 37468622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An atlas of epithelial cell states and plasticity in lung adenocarcinoma.
    Han G; Sinjab A; Rahal Z; Lynch AM; Treekitkarnmongkol W; Liu Y; Serrano AG; Feng J; Liang K; Khan K; Lu W; Hernandez SD; Liu Y; Cao X; Dai E; Pei G; Hu J; Abaya C; Gomez-Bolanos LI; Peng F; Chen M; Parra ER; Cascone T; Sepesi B; Moghaddam SJ; Scheet P; Negrao MV; Heymach JV; Li M; Dubinett SM; Stevenson CS; Spira AE; Fujimoto J; Solis LM; Wistuba II; Chen J; Wang L; Kadara H
    Nature; 2024 Mar; 627(8004):656-663. PubMed ID: 38418883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of tumorigenic cells in Kras(G12D)-induced lung adenocarcinoma.
    Cho HC; Lai CY; Shao LE; Yu J
    Cancer Res; 2011 Dec; 71(23):7250-8. PubMed ID: 22088965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling diverse genetic subtypes of lung adenocarcinoma with a next-generation alveolar type 2 organoid platform.
    Naranjo S; Cabana CM; LaFave LM; Romero R; Shanahan SL; Bhutkar A; Westcott PMK; Schenkel JM; Ghosh A; Liao LZ; Del Priore I; Yang D; Jacks T
    Genes Dev; 2022 Aug; 36(15-16):936-949. PubMed ID: 36175034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alveolar progenitor and stem cells in lung development, renewal and cancer.
    Desai TJ; Brownfield DG; Krasnow MA
    Nature; 2014 Mar; 507(7491):190-4. PubMed ID: 24499815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical requirement of SOS1 for tumor development and microenvironment modulation in KRAS
    Baltanás FC; García-Navas R; Rodríguez-Ramos P; Calzada N; Cuesta C; Borrajo J; Fuentes-Mateos R; Olarte-San Juan A; Vidaña N; Castellano E; Santos E
    Nat Commun; 2023 Sep; 14(1):5856. PubMed ID: 37730692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor of Differentiation-1 Sustains Mutant
    Román M; López I; Guruceaga E; Baraibar I; Ecay M; Collantes M; Nadal E; Vallejo A; Cadenas S; Miguel ME; Jang JH; Martin-Uriz PS; Castro-Labrador L; Vilas-Zornoza A; Lara-Astiaso D; Ponz-Sarvise M; Rolfo C; Santos ES; Raez LE; Taverna S; Behrens C; Weder W; Wistuba II; Vicent S; Gil-Bazo I
    Cancer Res; 2019 Feb; 79(3):625-638. PubMed ID: 30563891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EHMT2 methyltransferase governs cell identity in the lung and is required for KRAS
    Pribluda A; Daemen A; Lima AN; Wang X; Hafner M; Poon C; Modrusan Z; Katakam AK; Foreman O; Eastham J; Hung J; Haley B; Garcia JT; Jackson EL; Junttila MR
    Elife; 2022 Aug; 11():. PubMed ID: 35983994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alveolar progenitor cells and the origin of lung cancer.
    Sainz de Aja J; Dost AFM; Kim CF
    J Intern Med; 2021 May; 289(5):629-635. PubMed ID: 33340175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of
    Kim S; Kim J; Jung Y; Jun Y; Jung Y; Lee HY; Keum J; Park BJ; Lee J; Kim J; Lee S; Kim J
    Mol Cells; 2020 Jul; 43(7):619-631. PubMed ID: 32638704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The AMPK-HOXB9-KRAS axis regulates lung adenocarcinoma growth in response to cellular energy alterations.
    Wang T; Guo H; Li Q; Wu W; Yu M; Zhang L; Li C; Song J; Wang Z; Zhang J; Tang Y; Kang L; Zhang H; Zhan J
    Cell Rep; 2022 Aug; 40(8):111210. PubMed ID: 36001969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 governs an AT1 differentiation programme in lung cancer suppression.
    Kaiser AM; Gatto A; Hanson KJ; Zhao RL; Raj N; Ozawa MG; Seoane JA; Bieging-Rolett KT; Wang M; Li I; Trope WL; Liou DZ; Shrager JB; Plevritis SK; Newman AM; Van Rechem C; Attardi LD
    Nature; 2023 Jul; 619(7971):851-859. PubMed ID: 37468633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

  • 18. Club cells employ regeneration mechanisms during lung tumorigenesis.
    Chen Y; Toth R; Chocarro S; Weichenhan D; Hey J; Lutsik P; Sawall S; Stathopoulos GT; Plass C; Sotillo R
    Nat Commun; 2022 Aug; 13(1):4557. PubMed ID: 35931677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking-induced CCNA2 expression promotes lung adenocarcinoma tumorigenesis by boosting AT2/AT2-like cell differentiation.
    He Q; Qu M; Xu C; Wu L; Xu Y; Su J; Bao H; Shen T; He Y; Cai J; Xu D; Zeng LH; Wu X
    Cancer Lett; 2024 Jun; 592():216922. PubMed ID: 38704137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinoma.
    Li Z; Zhuang X; Pan CH; Yan Y; Thummalapalli R; Hallin J; Torborg S; Singhal A; Chang JC; Manchado E; Dow LE; Yaeger R; Christensen JG; Lowe SW; Rudin CM; Joost S; Tammela T
    bioRxiv; 2023 Oct; ():. PubMed ID: 37808711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.